FDA approves handheld device to assess traumatic brain injury

The Food and Drug Administration recently approved Ahead 300, a handheld medical device that helps clinicians diagnose a traumatic brain injury.

Advertisement

The device’s electroencephalography technology uses algorithms and machine learning to analyze patient data in various clinically relevant measures. The device then produces a digital report of the patient’s results to help clinicians assess the injury.

BrainScope, based in Bethesda, Md., developed the device, which it hopes to launch in the coming months.

More articles on supply chain:

UPS testing drones for emergency medical supply deliveries
Intermountain Healthcare recognizes 4 suppliers for outstanding work
Mylan working on EpiPen formulation with longer shelf life

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.